<DOC>
	<DOC>NCT01310387</DOC>
	<brief_summary>This study is: - A single-center, randomized, prospective controlled trial. - To prove superiority of active pain management group compared to control group by the percent of pain intensity difference of outpatients with lung cancer pain. - 204 patients will be recruited.</brief_summary>
	<brief_title>Prospective Study of Active Pain Management in Lung Cancer Outpatients (APM)</brief_title>
	<detailed_description>- The recruited patients in both group will be provided the education about pain-killer, and received medicines including opioids according to their numeric rating scale (NRS) - Active management group will be provided additional telephone counseling and dosage modification by specialized nurse for cancer pain. - The percent of pain intensity difference (%PID) - PID = (NRS of visit 1 - NRS of visit 3)/NRS of visit 1</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Outpatients with lung cancer. The patients with uncontrolled lung cancer pain more than and equal NRS 4 pain during previous 24 hours for background pain, or more than and equal 3 times/day for breakthrough painkiller medication. Over 20 yearold male or female. The patients can be able to received telephone counseling by investigator's decision. Drug or alcohol abusers. Childbearing women or pregnant women. The patients with moderate to severe psychiatric problems. The patients who have hypersensitivity to opioids.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Lung cancer</keyword>
	<keyword>Cancer pain</keyword>
	<keyword>Opioid</keyword>
</DOC>